2:
Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells.
Aquino A, Prete SP, Greiner JW, Giuliani A, Graziani G, Turriziani M, De Filippi R, Masci G, Bonmassar E, De Vecchis L.
Clin Cancer Res. 1998 Oct;4(10):2473-81.
PMID: 9796980 [PubMed - indexed for MEDLINE]
Related Articles
3:
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.
Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G.
J Immunol. 2005 Jul 15;175(2):820-8. Erratum in: J Immunol. 2005 Nov 1;175(9):6235. Prete, Salvatore [corrected to Prete, Salvatore Pasquale].
PMID: 16002679 [PubMed - indexed for MEDLINE]
Related Articles
4:
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.
Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G.
J Clin Oncol. 2005 Dec 10;23(35):8950-8. Epub 2005 Aug 1.
PMID: 16061910 [PubMed - indexed for MEDLINE]
Related Articles
6:
Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil.
Prete SP, Aquino A, Masci G, Orlando L, Giuliani A, De Santis S, De Vecchis L, De Filippi R, Greiner JW, Bonmassar E, Graziani G.
J Pharmacol Exp Ther. 1996 Dec;279(3):1574-81.
PMID: 8968385 [PubMed - indexed for MEDLINE]
Related Articles
7:
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.
Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini C, Petrioli R, Prete SP, De Vecchis L, Turriziani M, Giorgi G, Bonmassar E, Francini G.
Int J Cancer. 2003 Apr 20;104(4):437-45. Erratum in: Int J Cancer. 2003 Jul 20;105(6):882.
PMID: 12584740 [PubMed - indexed for MEDLINE]
Related Articles
8:
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report.
Aquino A, Prete SP, Balduzzi A, Fossile E, Formica V, Torino F, Bonmassar L, Di Giacomo A, Cappelletti D, Cardillo A, Graziani G.
J Chemother. 2002 Aug;14(4):412-6.
PMID: 12420861 [PubMed - indexed for MEDLINE]
Related Articles
9:
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Kalofonos HP, Aravantinos G, Kosmidis P, Papakostas P, Economopoulos T, Dimopoulos M, Skarlos D, Bamias A, Pectasides D, Chalkidou S, Karina M, Koutras A, Samantas E, Bacoyiannis C, Samelis GF, Basdanis G, Kalfarentzos F, Fountzilas G.
Ann Oncol. 2005 Jun;16(6):869-77. Epub 2005 Apr 26.
PMID: 15855226 [PubMed - indexed for MEDLINE]
Related Articles